Since even mild CKD has been associated with marked increases in bone FGF23 expression, the increased bone FGF23 expression in the liver and heart transplant recipients may, similar to the renal transplant recipients, reflect the presence of both CKD and immune suppression. This evidence concerns the gene FGF23 and benign neoplasm.